v3.26.3
Operating Segments
9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Operating Segments

 

11. Operating Segments

 

In accordance with ASC 280, “Segment Reporting”, the Company defines an operating segment as a business activity: (1) from which we may earn revenue and incur expenses; (2) whose operating results are regularly reviewed by the CODM to make decisions about resources to be allocated to the segment and assess its performance; and (3) for which discrete financial information is available.

 

The Company has two reporting segments, consisting of the Treatment and Services Segments, which are primarily based on a service offering approach and defined as follow:

 

TREATMENT SEGMENT includes:

 

  - nuclear, low-level radioactive, mixed waste (containing both hazardous and low-level radioactive constituents), hazardous and non-hazardous waste treatment, processing and disposal services primarily through four uniquely licensed and permitted treatment and storage facilities; and
  - R&D activities to identify, develop and implement innovative waste processing techniques for problematic waste streams.

 

SERVICES SEGMENT includes:

 

  - Technical services:

 

  ○ professional radiological measurement and site survey of large government and commercial installations using advanced methods, technology and engineering;
  ○ integrated occupational safety and health services including IH assessments; hazardous materials surveys, e.g., exposure monitoring; lead and asbestos management/abatement oversight; indoor air quality evaluations; health risk and exposure assessments; health & safety plan/program development, compliance auditing and training services; and OSHA citation assistance;
  ○ global technical services providing consulting, engineering, project management, waste management, environmental, and D&D field, technical, and management personnel and services to commercial and government customers; and
  ○ on-site waste management services to commercial and governmental customers.

 

  - Nuclear services:

 

  ○ technology-based services including engineering, D&D, specialty services and construction, logistics, transportation, processing and disposal;
  ○ remediation of nuclear licensed and federal facilities and the remediation cleanup of nuclear legacy sites. Such services capability includes project investigation; radiological engineering; partial and total plant D&D; facility decontamination, dismantling, demolition, and planning; site restoration; logistics; transportation; and emergency response; and

 

  - A company owned equipment calibration and maintenance laboratory that services, maintains, calibrates, and sources (i.e., rental) health physics, IH and customized NEOSH instrumentation.

 

 

The Company’s CODM is represented by its CEO and COO (or “CODM group”). The CODM group evaluates the performance of the Treatment and Services segments and allocates resources to each reporting segment based on revenue and income (loss) from operations by comparing actual results for these measures to budgeted and forecasted amounts on a monthly, quarterly and year-to-date basis. The Company’s CODM group does not evaluate and allocate resources for the reportable segments using assets, including expenditures for additions to long-lived assets; therefore, the Company does not disclose asset information for its reporting segments.

 

The Company’s reportable segments exclude corporate headquarters, which support the Company’s two reportable segments through executive management, finance, treasury, human resources, accounting, legal, and other corporate functions. The financial results of corporate headquarters are not included in segment income (loss) from operations, the measure reviewed by the CODM, and are presented as unallocated corporate expenses in the reconciliation of segment income (loss) from operations to consolidated income (loss) from continuing operations before income taxes. The Company’s reportable segments also exclude discontinued operations (see Note 10 – Discontinued Operations), which do not generate revenues.

 

The table below summarizes segment income (loss) from operations, the measure reviewed by the CODM, and reconciles this measure to consolidated loss from continuing operations before income taxes for the three and nine months ended September 30, 2026 and 2025. Significant segment expense categories included in segment income (loss) from operations include payroll and benefits, materials and supplies, disposal, transportation, and subcontract expenses. These expense categories are presented separately, where applicable. R&D expenses, while not considered a significant segment expense category, are also presented separately because they are regularly provided to the CODM (in thousands).

 

Segment Reporting for the Three Months Ended September 30, 2026

 

   Treatment   Services   Consolidated Total 
Revenue from external customers  $11,601   $6,347   $17,948 
Cost of Goods Sold:               
Payroll and benefits expenses   5,728    2,720      
Material and supplies expenses   1,969    —      
Disposal expenses   1,104    —      
Transportation expenses   260    —      
Subcontract expenses   —    1,088      
Other cost of goods sold (1)   2,765    1,762      
Total cost of goods sold   11,826    5,570      
Gross (loss) profit   (225)   777      
SG&A:               
Payroll and benefits   916    399      
Other SG&A (2)   416    179      
Total SG&A   1,332    578      
R&D   165    3      
Gain on disposal of property and equipment   —    (5)     
(Loss) income from operations  $(1,722)  $201    (1,521)
Interest income             240 
Interest expense             (80)
Interest expense-financing fees             (16)
Other income             114 
Unallocated corporate expenses (3)             (2,145)
Loss from continuing operations before taxes            $(3,408)


 

 

Segment Reporting for the Three Months Ended September 30, 2025

 

   Treatment   Services   Consolidated Total 
Revenue from external customers  $13,114   $4,340   $17,454 
Cost of Goods Sold:               
Payroll and benefits expenses   4,809    2,358      
Material and supplies expenses   2,158     —      
Disposal expenses   1,075     —      
Transportation expenses   361     —      
Subcontract expenses    —    118      
Other cost of goods sold (1)   2,445    1,573      
Total cost of goods sold   10,848    4,049      
Gross profit   2,266    291      
SG&A:               
Payroll and benefits   947    547      
Other SG&A (2)   386    199      
Total SG&A   1,333    746      
R&D   257    2      
Loss on disposal of property and equipment   4     —      
Income (loss) from operations  $672   $(457)   215 
Interest income             266 
Interest expense             (116)
Interest expense-financing fees             (22)
Other expense             (18)
Unallocated corporate expenses (3)             (2,087)
Loss from continuing operations before taxes            $(1,762)

 

Segment Reporting for the Nine Months Ended September 30, 2026

 

   Treatment   Services   Consolidated Total 
Revenue from external customers  $27,768   $14,191   $41,959 
Cost of Goods Sold:               
Payroll and benefits expenses   15,950    7,142      
Material and supplies expenses   4,887    —      
Disposal expenses   3,470    —      
Transportation expenses   1,085    —      
Subcontract expenses   —    1,759      
Other cost of goods sold (1)   8,087    4,412      
Total cost of goods sold   33,479    13,313      
Gross profit   (5,711)   878      
SG&A:               
Payroll and benefits   2,685    1,561      
Other SG&A (2)   1,371    242      
Total SG&A   4,056    1,803      
R&D   584    7      
Gain on disposal of property and equipment   —    (5)     
Loss from operations  $(10,351)  $(927)   (11,278)
Interest income             624 
Interest expense             (213)
Interest expense-financing fees             (59)
Other income             258 
Unallocated corporate expenses (3)             (6,378)
Loss from continuing operations before taxes            $(17,046)

 

Segment Reporting for the Nine Months Ended September 30, 2025

 

   Treatment   Services   Consolidated Total 
Revenue from external customers  $33,696   $12,263   $45,959 
Cost of Goods Sold:               
Payroll and benefits expenses   13,988    6,245      
Material and supplies expenses   4,744    —

      
Disposal expenses   2,391     —      
Transportation expenses   1,222     —      
Subcontract expenses    —    1,184      
Other cost of goods sold (1)   7,269    4,155      
Total cost of goods sold   29,614    11,584      
Gross profit   4,082    679      
SG&A:               
Payroll and benefits   2,763    1,732      
Other SG&A (2)   1,276    573      
Total SG&A   4,039    2,305      
R&D   780    29      
Loss (gain) on disposal of property and equipment   3    (5)     
Loss from operations  $(740)  $(1,650)   (2,390)
Interest income             901 
Interest expense             (351)
Interest expense-financing fees             (63)
Other income             171 
Unallocated corporate expenses (3)             (6,112)
Loss from continuing operations before taxes            $(7,844)

 

(1)

Other cost of goods sold for each reportable segment includes:

 

Treatment - lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside services and general expenses.

Services - material and supplies, disposal, transportation, lab, regulatory, repair and maintenance, depreciation and amortization, travel, outside services and general expenses.

   
(2)

Other SG&A for each reportable segment includes:

 

Treatment- depreciation and amortization, travel, outside services, repair and maintenance and general expenses.

Services- travel, outside services, repair and maintenance and general expenses.

   
(3) The following table reflects the unallocated corporate expenses. “Other” unallocated corporate expenses consists of repair and maintenance, depreciation and amortization, travel, public company, outside services, general and R&D expenses. (in thousands)

 

             
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Payroll and benefits  $998   $997   $2,919   $2,869 
Other   1,147    1,090    3,459    3,243 
Total  $2,145   $2,087   $6,378   $6,112 

 

 

The following table presents depreciation and amortization for the three and nine months ended September 30, (in thousand):

 

             
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Treatment  $454   $387   $1,358   $1,158 
Services   29    28    77    109 
Total segment   483    415    1,435    1,267 
Corporate   12    11    34    32 
Total  $495   $426   $1,469   $1,299